{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:38:50Z","timestamp":1765438730543,"version":"3.45.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK24031","P30DK090728"],"award-info":[{"award-number":["DK24031","P30DK090728"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["P30DK084567"],"award-info":[{"award-number":["P30DK084567"]}],"id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jhepr.2021.100345","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T12:29:46Z","timestamp":1628166586000},"page":"100345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3290-9879","authenticated-orcid":false,"given":"Tatyana","family":"Masyuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9688-4784","authenticated-orcid":false,"given":"Anatoliy","family":"Masyuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christy","family":"Trussoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brynn","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5386-8810","authenticated-orcid":false,"given":"Jingyi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3266-0831","authenticated-orcid":false,"given":"Nicholas","family":"LaRusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2021.100345_bib1","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/hep.29708","article-title":"Polycystic liver disease: the interplay of genes causative for hepatic and renal cystogenesis","volume":"67","author":"Masyuk","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100345_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MOG.0000000000000514","article-title":"Genetics of polycystic liver diseases","volume":"35","author":"Lee-Law","year":"2019","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhepr.2021.100345_bib3","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hep.29577","article-title":"Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target","volume":"67","author":"Masyuk","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100345_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/14728222.2020.1751818","article-title":"New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease","volume":"24","author":"Barten","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jhepr.2021.100345_bib5","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.cgh.2016.03.008","article-title":"Polycystic liver disease: the benefits of targeting cAMP","volume":"14","author":"Larusso","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100345_bib6","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2174\/1389450116666150427161743","article-title":"Therapeutic targets in polycystic liver disease","volume":"18","author":"Masyuk","year":"2017","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jhepr.2021.100345_bib7","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jhep.2017.11.024","article-title":"Clinical management of polycystic liver disease","volume":"68","author":"van Aerts","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100345_bib8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/j.gastro.2011.11.036","article-title":"Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease","volume":"142","author":"Masyuk","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100345_bib9","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1172\/JCI34922","article-title":"MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease","volume":"118","author":"Lee","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2021.100345_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/embor.2013.53","article-title":"Autophagy modulates miRNA-mediated gene silencing and selectively degrades AIN-1\/GW182 in C. elegans","volume":"14","author":"Zhang","year":"2013","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jhepr.2021.100345_bib11","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/ncb2611","article-title":"Selective autophagy degrades DICER and AGO2 and regulates miRNA activity","volume":"14","author":"Gibbings","year":"2012","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jhepr.2021.100345_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/hep.26659","article-title":"Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224","volume":"59","author":"Lan","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100345_bib13","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.celrep.2018.07.017","article-title":"Huntingtin aggregation impairs autophagy, leading to Argonaute-2 accumulation and global microRNA dysregulation","volume":"24","author":"Pircs","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhepr.2021.100345_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hep.26140","article-title":"Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases","volume":"58","author":"Masyuk","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100345_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/1471-2164-15-423","article-title":"CAP-miRSeq: a comprehensive analysis pipeline for microRNA sequencing data","volume":"15","author":"Sun","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jhepr.2021.100345_bib16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/2211-5463.12428","article-title":"Gene expression profiles and pathway enrichment analysis of human osteosarcoma cells exposed to sorafenib","volume":"8","author":"Dai","year":"2018","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.jhepr.2021.100345_bib17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nprot.2010.62","article-title":"Rapid in situ codetection of noncoding RNAs and proteins in cells and formalin-fixed paraffin-embedded tissue sections without protease treatment","volume":"5","author":"de Planell-Saguer","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jhepr.2021.100345_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajpath.2013.09.021","article-title":"Centrosomal abnormalities characterise human and rodent cystic cholangiocytes and are associated with Cdc25A overexpression","volume":"184","author":"Masyuk","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhepr.2021.100345_bib19","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","article-title":"Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate","volume":"132","author":"Masyuk","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100345_bib20","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.4161\/cc.8.9.8253","article-title":"MicroRNAs in cholangiociliopathies","volume":"8","author":"Masyuk","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jhepr.2021.100345_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224071","article-title":"Integrated analysis of miRNA landscape and cellular networking pathways in stage-specific prostate cancer","volume":"14","author":"Verma","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.jhepr.2021.100345_bib22","first-page":"771","article-title":"miRNA expression profiling regulates necroptotic cell death in hepatocellular carcinoma","volume":"53","author":"Visalli","year":"2018","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jhepr.2021.100345_bib23","first-page":"874","article-title":"Signatures of circulating microRNA in four sarcoma subtypes","volume":"11","author":"Kosela-Paterczyk","year":"2020","journal-title":"J\u00a0Canc"},{"key":"10.1016\/j.jhepr.2021.100345_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1752-0509-5-56","article-title":"Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease","volume":"5","author":"Pandey","year":"2011","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.jhepr.2021.100345_bib25","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/hep.29284","article-title":"TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate\/Galphas signaling","volume":"66","author":"Masyuk","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100345_bib26","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1053\/j.gastro.2011.04.030","article-title":"Polycystic liver diseases: congenital disorders of cholangiocyte signaling","volume":"140","author":"Strazzabosco","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100345_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MOG.0b013e328328f4ff","article-title":"Cholangiociliopathies: genetics, molecular mechanisms and potential therapies","volume":"25","author":"Masyuk","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhepr.2021.100345_bib28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrm.2017.60","article-title":"Genes and molecular pathways underpinning ciliopathies","volume":"18","author":"Reiter","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2021.100345_bib29","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/bjc.2015.252","article-title":"MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways","volume":"113","author":"Srivastava","year":"2015","journal-title":"Br J Canc"},{"key":"10.1016\/j.jhepr.2021.100345_bib30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00432-015-2016-0","article-title":"MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer","volume":"142","author":"Chen","year":"2016","journal-title":"J\u00a0Canc Res Clin Oncol"},{"key":"10.1016\/j.jhepr.2021.100345_bib31","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.biopha.2018.12.121","article-title":"MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8","volume":"111","author":"Mou","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jhepr.2021.100345_bib32","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/carcin\/bgr114","article-title":"MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and\u00a0invasion in human colorectal cancer","volume":"32","author":"Tang","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhepr.2021.100345_bib33","doi-asserted-by":"crossref","first-page":"104732","DOI":"10.1016\/j.archoralbio.2020.104732","article-title":"MicroRNA-345 functions as a tumor suppressor via targeting ZEB2 in oral squamous cell carcinoma","volume":"116","author":"Wu","year":"2020","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.jhepr.2021.100345_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/2211536605666161208154633","article-title":"Exploring mechanisms of microRNA downregulation in cancer","volume":"6","author":"Williams","year":"2017","journal-title":"MicroRNA"},{"key":"10.1016\/j.jhepr.2021.100345_bib35","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jmb.2016.02.004","article-title":"Mechanisms of selective autophagy","volume":"428","author":"Zaffagnini","year":"2016","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jhepr.2021.100345_bib36","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bulcan.2020.11.004","article-title":"An overview of autophagy: mechanism, regulation and research progress","volume":"108","author":"Cao","year":"2021","journal-title":"Bull Canc"},{"key":"10.1016\/j.jhepr.2021.100345_bib37","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00018-015-2104-y","article-title":"Autophagy inhibitors","volume":"73","author":"Pasquier","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jhepr.2021.100345_bib38","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012912","article-title":"The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers: a systematic review and meta-analysis","volume":"97","author":"Xu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhepr.2021.100345_bib39","doi-asserted-by":"crossref","first-page":"109548","DOI":"10.1016\/j.cellsig.2020.109548","article-title":"Modulation of polycystic kidney disease by non-coding RNAs","volume":"71","author":"Ramalingam","year":"2020","journal-title":"Cell Signal"},{"key":"10.1016\/j.jhepr.2021.100345_bib40","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1038\/s41467-019-11918-y","article-title":"Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease","volume":"10","author":"Lee","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2021.100345_bib41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","article-title":"Strategies, design, and chemistry in siRNA delivery systems","volume":"144","author":"Dong","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jhepr.2021.100345_bib42","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jid.2018.11.007","article-title":"A\u00a0microRNA-29 mimic (Remlarsen) represses extracellular matrix expression and fibroplasia in the skin","volume":"139","author":"Gallant-Behm","year":"2019","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592100121X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592100121X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:25:46Z","timestamp":1762899946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258955592100121X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S258955592100121X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100345","relation":{},"ISSN":["2589-5559"],"issn-type":[{"type":"print","value":"2589-5559"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100345"}}